Sample Publications by Recent Fellowship Graduates
Sample publications by recent graduates. Publications are listed under year of graduation with the name of the former fellow and their current affiliation. Recent graduates have taken on academic positions in many top hematology/oncology programs around the country.
2009
Monica Gramatges, MD, Assistant Professor, Pediatric Hematology/Oncology, Baylor College of Medicine
Neonatal alloimmune thrombocytopenia and neutropenia associated with maternal human leukocyte antigen antibodies, Pediatric Blood & Cancer, Volume 53, Issue 1, Date: 15 July 2009, Pages: 97-99, M. Monica Gramatges, Pauline Fani, Kari Nadeau, Shalini Pereira, Michael R. Jeng.
Jay Balatgas, MD, Instructor, Pediatric Hematology/Oncology, Stanford University
LIPOSOMAL AMPHOTERICIN B ASSOCIATED WITH SEVERE HYPERPHOSPHATEMIA, The Pediatric Infectious Disease Journal • Volume 27, Number 1, January 2008, Pages 77-79, Sutherland SM, Hong DK, Balagtas Jay, Gutierrez K, Dvorak CC, Sarwal M.
2008
Michael Wei, M.D., Clinical Instructor in Pediatric Hematology/Oncology, Stanford University
Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings.
Woolf KM, Wei MC, Link MP, Arber DA, Warnke RA., Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):196-201.
CpG island methylator phenotype and childhood leukemia.
Lacayo NJ, DiMartino JF, Wei MC, Dahl GV., Clin Cancer Res. 2006 Aug 15;12(16):4787-9.
The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes.
Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, Burstow D, Brown L., Heart Lung Circ. 2003;12(1):44-50.
Bcl-2-related genes in lymphoid neoplasia.
Wei MC., Int J Hematol. 2004 Oct;80(3):205-9. Review.
2007
Maureen O’Brien, M.D., Assistant Professor of Clinical Pediatrics, Hematology/Oncology, Cincinnati Children’s Hospital Medical Center, Ohio
Understanding the risk of second malignant tumors in children with Hodgkin's disease.
Donaldson SS, O'Brien MM.
Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):4-5
Acute leukemia in children.
O'Brien MM, Lacayo NJ.
Dis Mon. 2008 Apr;54(4):202-25.
Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421.
O'Brien MM, Taub JW, Chang MN, Massey GV, Stine KC, Raimondi SC, Becton D, Ravindranath Y, Dahl GV; Children's Oncology Group Study POG 9421. J Clin Oncol. 2008 Jan 20;26(3):414-20.
Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis.
O'Brien MM, Lee-Kim Y, George TI, McClain KL, Twist CJ, Jeng M. Pediatr Blood Cancer. 2008 Feb;50(2):381-3.
Joshua Schiffman, M.D., Assistant Professor, Pediatric Hematology/Oncology, University of Utah
Internet use among adolescent and young adults (AYA) with cancer.
Schiffman JD, Csongradi E, Suzuki LK. Pediatr Blood Cancer. 2008 Sep;51(3):410-5.
Introduction of a pediatric palliative care curriculum for pediatric residents.
Schiffman JD, Chamberlain LJ, Palmer L, Contro N, Sourkes B, Sectish TC. J Palliat Med. 2008 Mar;11(2):164-70.
Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia.
Hazard FK, Zhao S, Schiffman JD, Lacayo NJ, Dahl GV, Natkunam Y. Pediatr Dev Pathol. 2008 Jul-Aug;11(4):283-90. Epub 2007 Aug 3.
Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.
Schiffman JD, Chun N, Fisher PG, Dahl GV, Ford JM, Eggerding FA. Pediatr Blood Cancer. 2008 Apr;50(4):914-6.
The hemophagocytic syndrome: titrating continuous hemofiltration to the degree of lactic acidosis.
DiCarlo J, Lui WY, Frankel L, Howell W, Schiffman J, Alexander S. Pediatr Hematol Oncol. 2006 Oct-Nov;23(7):599-610.
2006
Dennis J. Kuo, M.D., Assistant Professor, Pediatric Hematology/Oncology, Columbia
University
Darbepoetin alfa and ferric gluconate ameliorate the anemia associated with recessive dystrophic epidermolysis bullosa.
Kuo DJ, Bruckner AL, Jeng MR. Pediatr Dermatol. 2006 Nov-Dec;23(6):580-5.
Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas.
Kuo DJ, Weiner HL, Wisoff J, Miller DC, Knopp EA, Finlay JL. J Pediatr Hematol Oncol. 2003 May;25(5):372-8.
2005
Nicola Bobey Wright, M.D., Clinical Assistant Professor, Pediatric Hematology/Oncology,
Alberta Children’s Hospital
SAFETY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN LESS THAN THREE YEARS OF AGE Christopher C. Dvorak; Nicola Bobey Wright; Wendy B. Wong; Karen M. Kristovich; Edward W. Matthews; Kenneth I. Weinberg; Michael D. Amylon; Rajni Agarwal
Pediatric Hematology and Oncology: Incorporating the International Journal of Pediatric Hematology/Oncology, 1521-0669, Volume 25, Issue 8, 2008, Pages 705 – 722
Anjali Sharma, MD, Pediatric Hematologist/Oncologist, Kaiser Permanente, Oakland
Monitoring pulmonary complications in long-term childhood cancer survivors: guidelines for the primary care physician. Liles A, Blatt J, Morris D, Wardrop R 3rd, Sharma A, Sznewajs A, Goldsby R; Children's Oncology Group. Cleve Clin J Med. 2008 Jul;75(7):531-9. Review.
Christopher Dvorak, MD, Assistant Clinical Professor, Pediatric Hematology/Oncology, UCSF
Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia.
Dvorak CC, Agarwal R, Dahl GV, Gregory JJ, Feusner JH. Biol Blood Marrow Transplant. 2008 Jul;14(7):824-30.
Liposomal amphotericin B associated with severe hyperphosphatemia.
Sutherland SM, Hong DK, Balagtas J, Gutierrez K, Dvorak CC, Sarwal M. Pediatr Infect Dis J. 2008 Jan;27(1):77-9.
Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy.
Dvorak CC, Sanders RP, Dahl GV, Donaldson SS, Razzouk BI. Pediatr Blood Cancer. 2007 May;48(5):582-5.
2004
Asha Pillai, MD, Assistant Professor, Pediatric Hematology/Oncology, St. Jude Children’s Research Hospital
Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
Pillai AB, George TI, Dutt S, Strober S. Blood. 2009 Apr 30;113(18):4458-67. Epub 2009 Feb 12.
Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation.
Pillai AB, George TI, Dutt S, Teo P, Strober S. J Immunol. 2007 May 15;178(10):6242-51.
Karen Rabin, MD, Assistant Professor, Pediatric Hematology/Oncology, Baylor College of Medicine
Malignancy in children with trisomy 21.
Rabin KR, Whitlock JA. Oncologist. 2009 Feb;14(2):164-73. Epub 2009 Jan 28.
Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia.
Gaikwad A, Rye CL, Devidas M, Heerema NA, Carroll AJ, Izraeli S, Plon SE, Basso G, Pession A, Rabin KR. Br J Haematol. 2009 Mar;144(6):930-2. Epub 2008 Dec 20.
Differential in vitro cytotoxicity does not explain increased host toxicities from chemotherapy in Down syndrome acute lymphoblastic leukemia.
Valle M, Plon SE, Rabin KR. Leuk Res. 2009 Feb;33(2):336-9. Epub 2008 Aug 20.
Personalized care of pediatric cancer patients.
Rabin K, Man TK, Lau CC. Nestle Nutr Workshop Ser Pediatr Program. 2008;62:173-85; discussion 185-8. Review.
Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia.
Rabin KR, Man TK, Yu A, Folsom MR, Zhao YJ, Rao PH, Plon SE, Naeem RC. Pediatr Blood Cancer. 2008 Aug;51(2):171-7.
Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer.
Giuriato S, Rabin K, Fan AC, Shachaf CM, Felsher DW. Semin Cancer Biol. 2004 Feb;14(1):3-11. Review.
2003
Wendy Wong, MD, Clinical Assistant Professor, Pediatric Hematology/Oncology, Stanford University
Safety of hematopoietic stem cell transplantation in children less than three years of age.
Dvorak CC, Wright NB, Wong WB, Kristovich KM, Matthews EW, Weinberg KI, Amylon MD, Agarwal R. Pediatr Hematol Oncol. 2008 Dec;25(8):705-22.
Idiopathic neutropenia of childhood is associated with Fas/FasL expression.
Nadeau KC, Callejas A, Wong WB, Joh JW, Cohen HJ, Jeng MR. Clin Immunol. 2008 Dec;129(3):438-47. Epub 2008 Sep 26.
Gene expression and pathway analysis of immune thrombocytopenic purpura.
Sood R, Wong W, Gotlib J, Jeng M, Zehnder JL. Br J Haematol. 2008 Jan;140(1):99-103. Epub 2007 Nov 12.
Cold agglutinin syndrome in pediatric liver transplant recipients.
Wong W, Merker JD, Nguyen C, Berquist W, Jeng M, Viele M, Glader B, Fontaine MJ. Pediatr Transplant. 2007 Dec;11(8):931-6.
Gene expression profile of idiopathic thrombocytopenic purpura (ITP).
Sood R, Wong W, Jeng M, Zehnder JL. Pediatr Blood Cancer. 2006 Oct 15;47(5 Suppl):675-7.
Daniel Kraft, MD, Instructor, Department of Stem Cell Biology and Regenerative Medicine,Stanford Univesity
Endochondral ossification is required for haematopoietic stem-cell niche formation.
Chan CK, Chen CC, Luppen CA, Kim JB, DeBoer AT, Wei K, Helms JA, Kuo CJ, Kraft DL, Weissman IL. Nature. 2009 Jan 22;457(7228):490-4. Epub 2008 Dec 10.
Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.
Czechowicz A, Kraft D, Weissman IL, Bhattacharya D. Science. 2007 Nov 23;318(5854):1296-9.
Aileen Cleary, MD, Director of Medical Affairs, Nodailty, Inc. Adjunct Clinical Assistant Professor, Pediatric Hematology/Oncology, Stanford University
Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
Jullien P, Cron RQ, Dabbagh K, Cleary A, Chen L, Tran P, Stepick-Biek P, Lewis DB. Int Immunol. 2003 Dec;15(12):1461-72.
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications.
Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, Altare F, Baretto R, Le Deist F, Kayal S, Koch H, Richter D, Brezina M, Aksu G, Wood P, Al-Jumaah S, Raspall M, Da Silva Duarte AJ, Tuerlinckx D, Virelizier JL, Fischer A, Enright A, Bernhöft J, Cleary AM, Vermylen C, Rodriguez-Gallego C, Davies G, Blütters-Sawatzki R, Siegrist CA, Ehlayel MS, Novelli V, Haas WH, Levy J, Freihorst J, Al-Hajjar S, Nadal D, De Moraes Vasconcelos D, Jeppsson O, Kutukculer N, Frecerova K, Caragol I, Lammas D, Kumararatne DS, Abel L, Casanova JL. J Exp Med. 2003 Feb 17;197(4):527-35.
Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor beta 1 deficiency.
Cleary AM, Tu W, Enright A, Giffon T, Dewaal-Malefyt R, Gutierrez K, Lewis DB. J Immunol. 2003 Jan 1;170(1):597-603.
Design and fabrication of a silica on silicon integrated optical biochip as a fluorescence microarray platform.
Ruano JM, Glidle A, Cleary A, Walmsley A, Aitchison JS, Cooper JM. Biosens Bioelectron. 2003 Mar;18(2-3):175-84.
Amplification of AML1 in childhood acute lymphoblastic leukemias.
Dal Cin P, Atkins L, Ford C, Ariyanayagam S, Armstrong SA, George R, Cleary A, Morton CC. Genes Chromosomes Cancer. 2001 Apr;30(4):407-9.
2002
Paivi Kinnunen, MD, Pediatrician, Finland
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes.
Lacayo NJ, Meshinchi S, Kinnunen P, Yu R, Wang Y, Stuber CM, Douglas L, Wahab R, Becton DL, Weinstein H, Chang MN, Willman CL, Radich JP, Tibshirani R, Ravindranath Y, Sikic BI, Dahl GV. Blood. 2004 Nov 1;104(9):2646-54. Epub 2004 Jul 13.
2001
Jennifer Willert, MD, Assistant Clinical Professor, UC San Diego
Prenatal diagnosis of fetal hepatoblastoma: case report and review of the literature.
Catanzarite V, Hilfiker M, Daneshmand S, Willert J.
J Ultrasound Med. 2008 Jul;27(7):1095-8.
PMID: 18577676
When disclosing a serious diagnosis to a minor conflicts with family values.
Gupta VB, Willert J, Pian M, Stein MT.
J Dev Behav Pediatr. 2008 Jun;29(3):231.
PMID: 18550993
Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma.
Navid F, Willert JR, McCarville MB, Furman W, Watkins A, Roberts W, Daw NC.
Cancer. 2008 Jul 15;113(2):419-25.
PMID: 18484657
Temozolomide and radiation for aggressive pediatric central nervous system malignancies.
Loh KC, Willert J, Meltzer H, Roberts W, Kerlin B, Kadota R, Levy M, White G, Geddis A, Schiff D, Martin L, Yu A, Kung F, Spear MA.
J Pediatr Hematol Oncol. 2005 May;27(5):254-8.
PMID: 15891559
Thrombocytopenia and severe hyperbilirubinemia in the neonatal period secondary to congenital thrombotic thrombocytopenic purpura and ADAMTS13 deficiency.
Schiff DE, Roberts WD, Willert J, Tsai HM.
J Pediatr Hematol Oncol. 2004 Aug;26(8):535-8.
PMID: 15284596
1999
Jorge Di Martino, MD, Associate Group Medical Director, Oncology Exploratory Clinical
Development at Genentech, Adjunct Clinical Assistant Professor at Stanford University School
of Medicine
1998
Michael Verneris, MD, Assistant Professor, Pediatric Hematology/Oncology, University of Minnesota
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.
Woll PS, Grzywacz B, Tian X, Marcus RK, Knorr DA, Verneris MR, Kaufman DS. Blood. 2009 Jun 11;113(24):6094-101. Epub 2009 Apr 13.
Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.
Brunstein CG, Wagner JE, Weisdorf DJ, Cooley S, Noreen H, Barker JN, DeFor T, Verneris MR, Blazar BR, Miller JS. Blood. 2009 May 28;113(22):5628-34. Epub 2009 Mar 27.
Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (Allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
Burke MJ, Trotz B, Luo X, Weisdorf DJ, Baker KS, Wagner JE, Verneris MR. Bone Marrow Transplant. 2009 Feb 9.
Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.
Bachanova V, Verneris MR, DeFor T, Brunstein CG, Weisdorf DJ. Blood. 2009 Mar 26;113(13):2902-5. Epub 2009 Jan 28.
Multimodality image guided total marrow irradiation and verification of the dose delivered to the lung, PTV, and thoracic bone in a patient: a case study.
Hui SK, Verneris MR, Froelich J, Dusenbery K, Welsh JS. Technol Cancer Res Treat. 2009 Feb;8(1):23-8.
Kaveri Suryanarayan, MD, Pediatric Hematologist/Oncologist, Ellicott City, MD
Nontuberculous mycobacterial infections in pediatric acute leukemia.
Suryanarayan K, Campbell J, Eskenazi AE. J Pediatr Hematol Oncol. 2002 Oct;24(7):558-60.
Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation.
Suryanarayan K, Natkunam Y, Berry G, Bangs CD, Cherry A, Dahl G. J Pediatr Hematol Oncol. 2001 Oct;23(7):452-5.
Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic factors and risk allocation.
Weitzman S, Suryanarayan K, Weinstein HJ. Curr Oncol Rep. 2002 Mar;4(2):107-13.
Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study.
Suryanarayan K, Shuster JJ, Donaldson SS, Hutchison RE, Murphy SB, Link MP. J Clin Oncol. 1999 Feb;17(2):456-9.
Wilms' tumour. Optimal treatment strategies.
Suryanarayan K, Marina N. Drugs. 1998 Oct;56(4):598-605.
1997
Kelly Look, MD, Pediatric Hematologist/Oncologist, Palo Alto Medical Foundation, Palo Alto,
CA
Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY, Blessing JA, Michener CM, Rubin SC, Ramirez PT; Gynecologic Oncology Group Study. Int J Gynecol Cancer. 2008 Jul-Aug;18(4):773-8.
Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
Bell J, Brady MF, Young RC, Lage J, Walker JL, Look KY, Rose GS, Spirtos NM; Gynecologic Oncology Group. Gynecol Oncol. 2006 Sep;102(3):432-9. Epub 2006 Jul 24.
Nadine Lee, MD, PhD, Pediatric Hematologist/Oncologist, Riley Hospital for Children, Indiana
False-positive metaiodobenzylguanidine scan for neuroblastoma in a child with opsoclonus-myoclonus syndrome treated with adrenocorticotropic hormone (acth).
McGarvey CK, Applegate K, Lee ND, Sokol DK. J Child Neurol. 2006 Jul;21(7):606-10.
Current issues in Wilms tumor management.
Grundy P, Perlman E, Rosen NS, Warwick AB, Glade Bender J, Ehrlich P, Hoffer FA, Lee ND. Curr Probl Cancer. 2005 Sep-Oct;29(5):221-60. Review.
Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus.
Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Lee ND, Fisher J, Jasty R. J Pediatr Hematol Oncol. 2004 Nov;26(11):718-23.
1996
Joan Fisher, MD, Pediatric Hematologist/Oncologist, Carilion Clinic, Virginia
Does linguistic input play the same role in language learning for children with and without early brain injury?
Rowe ML, Levine SC, Fisher JA, Goldin-Meadow S. Dev Psychol. 2009 Jan;45(1):90-102.
Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus.
Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Lee ND, Fisher J, Jasty R. J Pediatr Hematol Oncol. 2004 Nov;26(11):718-23.
Arun Rangaswami, MD, Clinical Associate Professor, Pediatric Hematology/Oncology, Stanford University
Effects of poloxamer 188 treatment on sickle cell vaso-occlusive crisis: computer-assisted intravital microscopy study.
Cheung AT, Chan MS, Ramanujam S, Rangaswami A, Curl K, Franklin P, Wun T. J Investig Med. 2004 Sep;52(6):402-6.
Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease.
Wun T, Cordoba M, Rangaswami A, Cheung AW, Paglieroni T. Clin Lab Haematol. 2002 Apr;24(2)81-8
Predictors of bacteremia in febrile children with sickle cell disease.
West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N. J Pediatr Hematol Oncol. 2002 May;24(4):279-83.
1995
Norman Lacayo, MD, Assistant Professor, Pediatric Hematology/Oncology, Stanford University
Genomics of childhood leukemias: the virtue of complexity.
Sikic BI, Tibshirani R, Lacayo NJ. J Clin Oncol. 2008 Sep 20;26(27):4367-8.
Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia.
Hazard FK, Zhao S, Schiffman JD, Lacayo NJ, Dahl GV, Natkunam Y. Pediatr Dev Pathol. 2008 Jul-Aug;11(4):283-90. Epub 2007 Aug 3.
The incidence and clinical significance of nucleophosmin mutations in childhood AML.
Brown P, McIntyre E, Rau R, Meshinchi S, Lacayo N, Dahl G, Alonzo TA, Chang M, Arceci RJ, Small D. Blood. 2007 Aug 1;110(3):979-85. Epub 2007 Apr 17.
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
Juric D, Lacayo NJ, Ramsey MC, Racevskis J, Wiernik PH, Rowe JM, Goldstone AH, O'Dwyer PJ, Paietta E, Sikic BI. J Clin Oncol. 2007 Apr 10;25(11):1341-9. Epub 2007 Feb 20.
CpG island methylator phenotype and childhood leukemia.
Lacayo NJ, DiMartino JF, Wei MC, Dahl GV. Clin Cancer Res. 2006 Aug 15;12(16):4787-9.
1994
Jeffrey Rubnitz, MD, Director of Pediatric Hematology/Oncology Fellowship Program, St. Jude
Treating childhood acute lymphoblastic leukemia without cranial irradiation.
Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV. N Engl J Med. 2009 Jun 25;360(26):2730-41.
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.
Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJ, Leszl A, Litvinko N, Lo Nigro L, Morimoto A, Perot C, Pieters R, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Zwaan CM, van den Heuvel-Eibrink MM. Blood. 2009 Jun 15.
Cutaneous infection caused by Macrophomina phaseolina in a child with acute myeloid leukemia.
Srinivasan A, Wickes BL, Romanelli AM, Debelenko L, Rubnitz JE, Sutton DA, Thompson EH, Fothergill AW, Rinaldi MG, Hayden RT, Shenep JL. J Clin Microbiol. 2009 Jun;47(6):1969-72. Epub 2009 Apr 22.
Levetiracetam as monotherapy for seizures in a neonate with acute lymphoblastic leukemia.
Ledet DS, Wheless JW, Rubnitz JE, Brannon Morris E. Eur J Paediatr Neurol. 2009 Jan 29.
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.
Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, Cheng C, Su X, Rubnitz JE, Basso G, Biondi A, Pui CH, Downing JR, Campana D. Lancet Oncol. 2009 Feb;10(2):147-56. Epub 2009 Jan 13.
Karol Kerr, MD, Pediatric Oncologist, University of South Florida
Nucleotide sequence and characterization of the pyrF operon of Escherichia coli K12.
Turnbough CL Jr, Kerr KH, Funderburg WR, Donahue JP, Powell FE.
J Biol Chem. 1987 Jul 25;262(21):10239-45
Louie Naumovski, MD, PhD
Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds.
Kampa KM, Acoba JD, Chen D, Gay J, Lee H, Beemer K, Padiernos E, Boonmark N, Zhu Z, Fan AC, Bailey AS, Fleming WH, Corless C, Felsher DW, Naumovski L, Lopez CD.
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4390-5. Epub 2009 Feb 26.
PMID: 19251665
Synthesis and biologic properties of hydrophilic sapphyrins, a new class of tumor-selective inhibitors of gene expression.
Wang Z, Lecane PS, Thiemann P, Fan Q, Cortez C, Ma X, Tonev D, Miles D, Naumovski L, Miller RA, Magda D, Cho DG, Sessler JL, Pike BL, Yeligar SM, Karaman MW, Hacia JG.
Mol Cancer. 2007 Jan 19;6:9.
PMID: 17233922
Tumor localization and antitumor efficacy of novel sapphyrin compounds.
Naumovski L, Sirisawad M, Lecane P, Chen J, Ramos J, Wang Z, Cortez C, Magda D, Thiemann P, Boswell G, Miles D, Cho DG, Sessler JL, Miller R.
Mol Cancer Ther. 2006 Nov;5(11):2798-805.
PMID: 17121926
Motexafin gadolinium-induced cell death correlates with heme oxygenase-1 expression and inhibition of P450 reductase-dependent activities.
Evans JP, Xu F, Sirisawad M, Miller R, Naumovski L, de Montellano PR.
Mol Pharmacol. 2007 Jan;71(1):193-200. Epub 2006 Oct 3.
PMID: 17018578
G80A reduced folate carrier SNP influences the absorption and cellular translocation of dietary folate and its association with blood pressure in an elderly population.
Dufficy L, Naumovski N, Ng X, Blades B, Yates Z, Travers C, Lewis P, Sturm J, Veysey M, Roach PD, Lucock MD.
Life Sci. 2006 Aug 1;79(10):957-66. Epub 2006 May 17.
PMID: 16750224
1993
Mark Mogul, MD
1992
Richard J. Bram, MD, Pediatric Hematologist/Oncologist, Mayo Clinic, Minnesota
CAML loss causes anaphase failure and chromosome missegregation.
Liu Y, Malureanu L, Jeganathan KB, Tran DD, Lindquist LD, van Deursen JM, Bram RJ.
Cell Cycle. 2009 Mar 15;8(6):940-9. Epub 2009 Mar 26.
TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens.
Mantchev GT, Cortesão CS, Rebrovich M, Cascalho M, Bram RJ.
J Immunol. 2007 Aug 15;179(4):2282-8.
Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease.
Murali NS, Ackerman AW, Croatt AJ, Cheng J, Grande JP, Sutor SL, Bram RJ, Bren GD, Badley AD, Alam J, Nath KA.
Selective activation of TACI by syndecan-2.
Bischof D, Elsawa SF, Mantchev G, Yoon J, Michels GE, Nilson A, Sutor SL, Platt JL, Ansell SM, von Bulow G, Bram RJ.
Blood. 2006 Apr 15;107(8):3235-42. Epub 2005 Dec 15.
CAML is a p56Lck-interacting protein that is required for thymocyte development.
Tran DD, Edgar CE, Heckman KL, Sutor SL, Huntoon CJ, van Deursen J, McKean DL, Bram RJ.
Immunity. 2005 Aug;23(2):139-52.
Maritza Gonzalez-Navarrete, MD, General Pediatrician, Santa Clara Valley Medical Center
1991
Paulette Bryant, MD, Pediatric Hematologist/Oncologist, Presbyterian Blume Pediatric
Hematology and Oncology Clinic , North Carolina
Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa.
CLINICAL LABORATORY JOURNAL FOR CLINICAL LABORATORIES AND LABORATORIES RELATED [1433-6510] Bryant yr:2004 vol:50 iss:9-10 pg:529 -38
Sandra Luna-Fineman, MD, Clinical Associate Professor, Pediatric Hematology/Oncology, Stanford University School of Medicine,California
Development of retinoblastoma programs in Central America.
Wilimas JA, Wilson MW, Haik BG, Barnoya M, Fu L, Castellanos M, Bonilla M, Phillips B, Helveston EM, Luna-Fineman S, Ribeiro R, Rodriguez-Galindo C.
Pediatr Blood Cancer. 2009 Jul;53(1):42-6.
PMID: 19326423
Treating Pediatric soft tissue sarcomas in a country with limited resources: the experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala.
Antillon F, Castellanos M, Valverde P, Luna-Fineman S, Garrido C, Serrato T, Rodriguez-Galindo C, Casanova M, Ferrari A.
Pediatr Blood Cancer. 2008 Dec;51(6):760-4.
PMID: 18680154
Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.
Lange BJ, Smith FO, Feusner J, Barnard DR, Dinndorf P, Feig S, Heerema NA, Arndt C, Arceci RJ, Seibel N, Weiman M, Dusenbery K, Shannon K, Luna-Fineman S, Gerbing RB, Alonzo TA.
Blood. 2008 Feb 1;111(3):1044-53. Epub 2007 Nov 13.
PMID: 18000167
Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I.
Howard SC, Marinoni M, Castillo L, Bonilla M, Tognoni G, Luna-Fineman S, Antillon F, Valsecchi MG, Pui CH, Ribeiro RC, Sala A, Barr RD, Masera G; MISPHO Consortium Writing Committee.
Pediatr Blood Cancer. 2007 Mar;48(3):364-9.
PMID: 16883601
Poliovirus excretion in Guatemalan adults and children with HIV infection and children with cancer.
Asturias EJ, Grazioso CF, Luna-Fineman S, Torres O, Halsey NA.
Biologicals. 2006 Jun;34(2):109-12. Epub 2006 May 8.
PMID: 16682223
Stephen P. Hunger, MD, Professor of Pediatrics, Hematology, Oncology and Bone Marrow
Transplantation, The Ergen Family Chair in Pediatric Cancer, University of Colorado, Denver
1990
Carolyn Russo, MD, Medical Director, Pediatric Hematology/Oncology, St. Jude Huntsville Hospital, Alabama
The bereaved parent.
Russo C, Wong AF.
J Clin Oncol. 2005 Nov 1;23(31):8109-11. Review. No abstract available.
PMID: 16258108
Vaccination history and risk of childhood leukaemia.
Ma X, Does MB, Metayer C, Russo C, Wong A, Buffler PA.
Int J Epidemiol. 2005 Oct;34(5):1100-9. Epub 2005 Jun 10.
PMID: 15951359
Apparent genotype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome.
Karim MA, Suzuki K, Fukai K, Oh J, Nagle DL, Moore KJ, Barbosa E, Falik-Borenstein T, Filipovich A, Ishida Y, Kivrikko S, Klein C, Kreuz F, Levin A, Miyajima H, Regueiro J, Russo C, Uyama E, Vierimaa O, Spritz RA.
Am J Med Genet. 2002 Feb 15;108(1):16-22.
PMID: 11857544
1989
Steven K. Bergstrom, MD, Pediatric Hematologist/Oncologist, Kaiser Permanente, Oakland, CA
